Article
Merck's Keytruda gets FDA nod for expanded use in lung cancer
Rating:
0.0
Views:
48
Likes:
1
Library:
1
The U.S. Food and Drug Administration on Monday approved the expanded use of Merck & Co's blockbuster immunotherapy Keytruda in early-stage patients with non-small cell lung cancer who can get their tumors removed surgically.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value